IGOR ROMANOV: Open Payments
NPI 1457565269 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,363 in 39 payments from 15 companies in 2025. Trend: 2023 $3,290 · 2024 $2,262 · 2025 $1,363
Food & beverage: $1,169Education: $194
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $231 |
| Incyte Corporation | 7 | $226 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $217 |
| GENZYME CORPORATION | 3 | $169 |
| ABBVIE INC. | 4 | $114 |
| Organon LLC | 4 | $91 |
| LEO Pharma Inc. | 2 | $52 |
| Amgen Inc. | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 2 | $42 |
| Novartis Pharmaceuticals Corporation | 1 | $35 |
Products named: TREMFYA, OPZELURA, DUPIXENT, SKYRIZI, VTAMA, ADBRY, OTEZLA, COSENTYX.
Industry payments across NY — which companies pay providers there.
